ARTICLE | Distillery Therapeutics
Infectious disease
December 22, 2016 12:44 AM UTC
In vitro studies identified an phenyldiazole-based inhibitor of DDX39B ATPase activity that could help treat HSV and other Herpesviridae viral infections. In silico screening of a small molecule libra...
BCIQ Company Profiles
BCIQ Target Profiles